tetano
Editor, Senior Moderator
Proc Natl Acad Sci U S A
. 2021 Feb 23;118(8):e2021830118.
doi: 10.1073/pnas.2021830118.
Exhaled aerosol increases with COVID-19 infection, age, and obesity
David A Edwards[SUP] 1 2 [/SUP], Dennis Ausiello[SUP] 3 [/SUP], Jonathan Salzman[SUP] 2 [/SUP], Tom Devlin[SUP] 2 [/SUP], Robert Langer[SUP] 4 [/SUP], Brandon J Beddingfield[SUP] 5 [/SUP], Alyssa C Fears[SUP] 5 [/SUP], Lara A Doyle-Meyers[SUP] 5 [/SUP], Rachel K Redmann[SUP] 5 [/SUP], Stephanie Z Killeen[SUP] 5 [/SUP], Nicholas J Maness[SUP] 5 [/SUP], Chad J Roy[SUP] 6 7 [/SUP]
Affiliations
Abstract
COVID-19 transmits by droplets generated from surfaces of airway mucus during processes of respiration within hosts infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. We studied respiratory droplet generation and exhalation in human and nonhuman primate subjects with and without COVID-19 infection to explore whether SARS-CoV-2 infection, and other changes in physiological state, translate into observable evolution of numbers and sizes of exhaled respiratory droplets in healthy and diseased subjects. In our observational cohort study of the exhaled breath particles of 194 healthy human subjects, and in our experimental infection study of eight nonhuman primates infected, by aerosol, with SARS-CoV-2, we found that exhaled aerosol particles vary between subjects by three orders of magnitude, with exhaled respiratory droplet number increasing with degree of COVID-19 infection and elevated BMI-years. We observed that 18% of human subjects (35) accounted for 80% of the exhaled bioaerosol of the group (194), reflecting a superspreader distribution of bioaerosol analogous to a classical 20:80 superspreader of infection distribution. These findings suggest that quantitative assessment and control of exhaled aerosol may be critical to slowing the airborne spread of COVID-19 in the absence of an effective and widely disseminated vaccine.
Keywords: COVID-19; aerosols; respiratory medicine; superspreaders.
. 2021 Feb 23;118(8):e2021830118.
doi: 10.1073/pnas.2021830118.
Exhaled aerosol increases with COVID-19 infection, age, and obesity
David A Edwards[SUP] 1 2 [/SUP], Dennis Ausiello[SUP] 3 [/SUP], Jonathan Salzman[SUP] 2 [/SUP], Tom Devlin[SUP] 2 [/SUP], Robert Langer[SUP] 4 [/SUP], Brandon J Beddingfield[SUP] 5 [/SUP], Alyssa C Fears[SUP] 5 [/SUP], Lara A Doyle-Meyers[SUP] 5 [/SUP], Rachel K Redmann[SUP] 5 [/SUP], Stephanie Z Killeen[SUP] 5 [/SUP], Nicholas J Maness[SUP] 5 [/SUP], Chad J Roy[SUP] 6 7 [/SUP]
Affiliations
- PMID: 33563754
- DOI: 10.1073/pnas.2021830118
Abstract
COVID-19 transmits by droplets generated from surfaces of airway mucus during processes of respiration within hosts infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. We studied respiratory droplet generation and exhalation in human and nonhuman primate subjects with and without COVID-19 infection to explore whether SARS-CoV-2 infection, and other changes in physiological state, translate into observable evolution of numbers and sizes of exhaled respiratory droplets in healthy and diseased subjects. In our observational cohort study of the exhaled breath particles of 194 healthy human subjects, and in our experimental infection study of eight nonhuman primates infected, by aerosol, with SARS-CoV-2, we found that exhaled aerosol particles vary between subjects by three orders of magnitude, with exhaled respiratory droplet number increasing with degree of COVID-19 infection and elevated BMI-years. We observed that 18% of human subjects (35) accounted for 80% of the exhaled bioaerosol of the group (194), reflecting a superspreader distribution of bioaerosol analogous to a classical 20:80 superspreader of infection distribution. These findings suggest that quantitative assessment and control of exhaled aerosol may be critical to slowing the airborne spread of COVID-19 in the absence of an effective and widely disseminated vaccine.
Keywords: COVID-19; aerosols; respiratory medicine; superspreaders.